It has been recently revealed in a report that a new measure has been found for the detection of ovarian cancer. A recent study done by a team from the Garvan Institute in Sydney might soon be able to look out for ovarian cancer in the time to come.

For the same, the whole genome was used for the identification of those six genes which are responsible for the onset of the disease. This is usually associated with DNA methylation, which is a part of most ovarian cancers.

This discovery might soon lead to new measures for the early detection of the disease. This is one of the most prevalent and dangerous types of cancer. It is one of the most common cancer types in women. It is essential that the disease is identified at the correct time; otherwise it might lead to devastating effects. There are many women dying every year due to the disease in the world. It is essential that there is even more research and development done for finding an effective mode of treatment for the disease in the time to come.

An early diagnosis might mean treatment could start early and the life of the women can be saved.

“This was one of first studies that used whole genome techniques to directly profile DNA methylation aberrations in ovarian cancer – with the aim of identifying diagnostic biomarkers. One of the key methylated genes we identified was a novel gene”, said Brian Gloss, who is studying this subject in his PhD.

There is need for a little more research and development to be done in this regard, so as to make this a potential way of diagnosis for the disease that could help save millions of lives in the future.